Retatrutide calculator
Enter the mg on the vial, the water you added and the dose in mg, and see where to draw on your syringe. Below: the doses studied in trials, and where approval stands.
It's printed on the vial label, for example 10mg. This is the powder before any water goes in.
Where is it on the label?
The amount is the big figure on the label, in mg. Ignore the volume of water or the batch number.
Use the number and unit exactly as you were given it. Doses under 1 mg are usually written in mcg (micrograms). 1 mg is 1,000 mcg.
Bacteriostatic water, in mL. If you're not sure, check what you wrote down when you mixed it.
Look at the biggest number printed on the side of the syringe.
Not sure? See the three sizes
All three are U-100 insulin syringes: 100 units is 1 mL. The top mark tells you which one you have. A 1 mL syringe has a line every 2 units, so count carefully.
Divide the mg in the vial by the mL of water to get the strength, then divide the dose by the strength and multiply by 100 for units. Example: 10 mg of retatrutide with 2 mL of water is 5 mg/mL, so 2 mg is 0.4 mL, or 40 units on a U-100 syringe.
Every step is shown
Open "Show the maths" and you can check each line yourself, or show it to someone you trust.
We catch the common slips
Mixing up mg and mcg, or picking the wrong syringe, are the usual mistakes. We flag both before you draw.
Nothing to sell you
No shop, no seller links, no account. Your numbers stay on your device.
Is retatrutide FDA approved?
Not approved As of 2026-10-07, retatrutide is not approved by the FDA for any use. It is an investigational medicine made by Eli Lilly and is in phase 3 trials (the TRIUMPH programme, for example NCT05929066). Lilly has also registered a pre-approval expanded access programme (NCT07629401).
Retatrutide sold outside a trial or Lilly's programme is not an approved product. Its strength and purity can't be checked from the label, which is one more reason to check your maths twice.
Doses studied in trials
In the published phase 2 trial, adults with obesity took retatrutide once a week for 48 weeks at one of these doses. Several groups started lower and stepped up. This is what was studied, not a recommendation.
| Trial group | Weekly dose |
|---|---|
| Low | 1 mg |
| Middle | 4 mg (two groups: started at 2 mg, or at 4 mg) |
| Higher | 8 mg (two groups: started at 2 mg, or at 4 mg) |
| Highest | 12 mg (started at 2 mg) |
How much water for a 10 mg vial?
Any amount works as long as you use the same number when you calculate. Here's what 2 mg looks like on a 1 mL syringe for common choices:
| Vial | Water | Strength | 2 mg is | Doses per vial |
|---|---|---|---|---|
| 10 mg | 1 mL | 10 mg/mL | 20 units (0.2 mL) | 5 |
| 10 mg | 2 mL | 5 mg/mL | 40 units (0.4 mL) | 5 |
| 10 mg | 3 mL | 3.33 mg/mL | 60 units (0.6 mL) | 5 |
Not mixed yet? The reconstitution calculator shows which water amounts land on a line.
Sources
- Jastreboff AM et al. Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial. N Engl J Med 2023;389:514-526: nejm.org
- TRIUMPH-1 phase 3 trial record: clinicaltrials.gov
- Pre-approval expanded access of retatrutide: clinicaltrials.gov